ADMS insider filings

Adamas Pharmaceuticals Inc — 34 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2021-11-24. Screen ADMS transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ADMS between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Adamas Pharmaceuticals Inc

FiledFormInsiderReported transactionsSource
2021-11-244McFarlane Neil F. — Chief Executive Officer, DirectorGrant/award (A): 75,000 @ $0 · Code (U): 600,000 · Disposition to issuer (D): 250,000 (derivative) · Disposition to issuer (D): 200,000 (derivative)EDGAR
2021-11-244Prentiss Christopher B — Chief Financial OfficerGrant/award (A): 18,750 @ $0 · Code (U): 163,767 · Disposition to issuer (D): 37,500 (derivative) · Disposition to issuer (D): 50,000 (derivative)EDGAR
2021-11-244Ericson William W. — Director, 10% ownerCode (U): 10,000 · Code (U): 4,031,804 · Code (U): 6,043 · Code (U): 3,146 · Code (U): 25,661 · Code (U): 287,992 · +4 moreEDGAR
2021-11-244Shreedhar Vijay — Chief Commercial OfficerGrant/award (A): 18,750 @ $0 · Code (U): 186,786 · Disposition to issuer (D): 137,500 (derivative) · Disposition to issuer (D): 47,500 (derivative)EDGAR
2021-11-244Papapetropoulos Spyridon — DirectorCode (U): 20,975 · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 10,000 (derivative)EDGAR
2021-11-244MacPhee John A — DirectorCode (U): 202,000 · Disposition to issuer (D): 24,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative)EDGAR
2021-11-244MAHONEY DAVID L — DirectorCode (U): 5,000 · Code (U): 112,781 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative)EDGAR
2021-11-244BIGHAM MICHAEL — DirectorCode (U): 10,000 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative)EDGAR
2021-11-244RICHO ANNA — DirectorCode (U): 25,000 · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 10,000 (derivative)EDGAR
2021-11-244DEMSKI MARTHA J — DirectorCode (U): 16,000 · Code (U): 5,000 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative)EDGAR
2021-06-234Shreedhar Vijay — Chief Commercial OfficerSale (S): 6,200 @ $5.16EDGAR
2021-06-084DEMSKI MARTHA J — DirectorSale (S): 2,000 @ $5.17EDGAR
2021-06-044Papapetropoulos Spyridon — DirectorGrant/award (A): 5,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-044MacPhee John A — DirectorGrant/award (A): 5,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-044Ericson William W. — Director, 10% ownerGrant/award (A): 5,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-044Dier Mardi — DirectorGrant/award (A): 5,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-044MAHONEY DAVID L — DirectorGrant/award (A): 5,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-044BIGHAM MICHAEL — DirectorGrant/award (A): 5,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-044RICHO ANNA — DirectorGrant/award (A): 5,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-044DEMSKI MARTHA J — DirectorGrant/award (A): 5,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-03-234Shreedhar Vijay — Chief Commercial OfficerSale (S): 1,051 @ $5.50EDGAR
2021-03-234Prentiss Christopher B — Chief Financial OfficerSale (S): 2,422 @ $5.48EDGAR
2021-03-164MacPhee John A — DirectorOption exercise (M): 192,000 @ $0.67 · Option exercise (M): 192,000 (derivative) @ $0EDGAR
2021-03-164MAHONEY DAVID L — DirectorOption exercise (M): 48,000 @ $0.67 · Option exercise (M): 48,000 (derivative) @ $0EDGAR
2021-03-154Papapetropoulos Spyridon — DirectorPurchase (P): 5,975 @ $5.06EDGAR
2021-03-034McFarlane Neil F. — Chief Executive OfficerGrant/award (A): 300,000 @ $0EDGAR
2021-03-034Shreedhar Vijay — Chief Commercial OfficerGrant/award (A): 75,000 @ $0EDGAR
2021-03-034Prentiss Christopher B — Chief Financial OfficerGrant/award (A): 75,000 @ $0EDGAR
2021-02-014Prentiss Christopher B — Chief Financial OfficerSale (S): 3,821 @ $6.36EDGAR
2021-02-014Shreedhar Vijay — Chief Commercial OfficerSale (S): 4,514 @ $6.39EDGAR
2021-01-224Prentiss Christopher B — Chief Financial OfficerSale (S): 2,630 @ $4.41EDGAR
2020-11-244Papapetropoulos Spyridon — DirectorGrant/award (A): 10,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2020-11-024Prentiss Christopher B — Chief Financial OfficerSale (S): 2,050 @ $3.21EDGAR
2020-09-014RICHO ANNA — DirectorGrant/award (A): 10,000 @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR

Recent 8-K events — Adamas Pharmaceuticals Inc

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2021-11-248-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2021-10-128-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2021-08-098-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2021-06-118-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2021-06-048-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2021-05-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2021-02-258-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2021-02-238-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2021-02-018-K1.01 — Entry into a Material Definitive AgreementEDGAR
2021-01-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ADMS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs